Literature DB >> 9596750

Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

W J Hopkins1, A Gendron-Fitzpatrick, E Balish, D T Uehling.   

Abstract

Recurrent urinary tract infections (UTIs) are a significant clinical problem for many women; however, host susceptibility factors have not been completely defined. The mouse model of induced UTI provides an experimental environment in which to identify specific host characteristics that are important in initial bacterial colonization of the urinary tract and in resolution of an infection. This study examined initial susceptibility, bacterial clearance, and host defense mechanisms during induction and resolution of Escherichia coli UTIs in genetically distinct strains of mice. Of the ten inbred strains tested, six (BALB/c, C3H/HeN, C57BL/6, DBA.1, DBA.2, and AKR) showed progressive resolution of bladder infections over a 14-day period. A constant, low-level bladder infection was observed in SWR and SJL mice. High bladder infection levels persisted over the 14-day study period in C3H/HeJ and C3H/OuJ mice. Kidney infection levels generally correlated with bladder infection levels, especially in C3H/HeJ and C3H/OuJ mice, the two most susceptible strains, in which infections became more severe with time after challenge. The degree of inflammation in bladder and kidneys, as well as antibody-forming cell responses, positively correlated with infection intensity in all strains except C3H/HeJ, which had minimal inflammation despite high infection levels. These results demonstrate two important aspects of host defense against UTI. First, the innate immune response to an infection in the bladder or kidneys consists primarily of local inflammation, which is followed by an adaptive response characterized in part by an antibody response to the infecting bacteria. Second, a UTI will be spontaneously resolved in most cases; however, in mice with specific genetic backgrounds, a UTI can persist for an extended length of time. The latter result strongly suggests that the presence or absence of specific host genes will determine how effectively an E. coli UTI will be resolved.

Entities:  

Mesh:

Year:  1998        PMID: 9596750      PMCID: PMC108272          DOI: 10.1128/IAI.66.6.2798-2802.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Heritability of the phytohemagglutinin responsiveness of lymphocytes and its relationship to leukemogenesis.

Authors:  H J Heiniger; B A Taylor; E J Hards; H Meier
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

2.  Difference in B cell mitogen responsiveness between closely related strains of mice.

Authors:  D L Rosenstreich; L M Glode
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

3.  The immunologic basis of recurrent bacteriuria: role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa.

Authors:  T A Stamey; N Wehner; G Mihara; M Condy
Journal:  Medicine (Baltimore)       Date:  1978-01       Impact factor: 1.889

4.  Genetics of the immune response. I. The immune response to the phage fd in high and low responding inbred strains of mice.

Authors:  E Kölsch; E Diller; G Weber; A J Davies
Journal:  Eur J Immunol       Date:  1971-06       Impact factor: 5.532

5.  Immune response to porins isolated from Salmonella typhi in different mouse strains.

Authors:  C R González; M V Mejía; J Paniagua; V Ortíz-Navarrete; G Ramírez; A Isibasi
Journal:  Arch Med Res       Date:  1995       Impact factor: 2.235

6.  The role of vaginal immunoglobulin A in girls with recurrent urinary tract infections.

Authors:  J P Tuttle; H Sarvas; J Koistinen
Journal:  J Urol       Date:  1978-12       Impact factor: 7.450

7.  Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections.

Authors:  A J Schaeffer; J M Jones; J K Dunn
Journal:  N Engl J Med       Date:  1981-04-30       Impact factor: 91.245

8.  ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women.

Authors:  D F Kinane; C C Blackwell; R P Brettle; D M Weir; F P Winstanley; R A Elton
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

9.  Thymus independence of a collagen-like synthetic polypeptide and of collagen, and the need for thymus and bone marrow-cell cooperation in the immune response to gelatin.

Authors:  S Fuchs; E Mozes; A Maoz; M Sela
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

10.  H-2-linked genetic control of immune responsiveness to ovalbumin and ovomucoid.

Authors:  N M Vaz; J M Phillips-Quagliata; B B Levine; E M Vaz
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

View more
  64 in total

1.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  Transurethral induction of mouse urinary tract infection.

Authors:  Kim H Thai; Anuradha Thathireddy; Michael H Hsieh
Journal:  J Vis Exp       Date:  2010-08-05       Impact factor: 1.355

Review 4.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

5.  Reflux in the mouse model of urinary tract infection.

Authors:  J R Johnson
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.

Authors:  Corinne K Garofalo; Thomas M Hooton; Steven M Martin; Walter E Stamm; Joseph J Palermo; Jeffrey I Gordon; Scott J Hultgren
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

7.  Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.

Authors:  Matt S Conover; Ségolène Ruer; Joemar Taganna; Vasilios Kalas; Henri De Greve; Jerome S Pinkner; Karen W Dodson; Han Remaut; Scott J Hultgren
Journal:  Cell Host Microbe       Date:  2016-09-22       Impact factor: 21.023

8.  α-Intercalated cells defend the urinary system from bacterial infection.

Authors:  Neal Paragas; Ritwij Kulkarni; Max Werth; Kai M Schmidt-Ott; Catherine Forster; Rong Deng; Qingyin Zhang; Eugenia Singer; Alexander D Klose; Tian Huai Shen; Kevin P Francis; Sunetra Ray; Soundarapandian Vijayakumar; Samuel Seward; Mary E Bovino; Katherine Xu; Yared Takabe; Fábio E Amaral; Sumit Mohan; Rebecca Wax; Kaitlyn Corbin; Simone Sanna-Cherchi; Kiyoshi Mori; Lynne Johnson; Thomas Nickolas; Vivette D'Agati; Chyuan-Sheng Lin; Andong Qiu; Qais Al-Awqati; Adam J Ratner; Jonathan Barasch
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

9.  Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.

Authors:  Thomas J Hannan; Indira U Mysorekar; Chia S Hung; Megan L Isaacson-Schmid; Scott J Hultgren
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

10.  Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia.

Authors:  Sara N Smith; Erin C Hagan; M Chelsea Lane; Harry L T Mobley
Journal:  mBio       Date:  2010-11-23       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.